PCI Pharma Services has appointed Melissa Ertl as executive director of quality at its Philadelphia location. The site serves as the corporate headquarters as well as a center of excellence for contract packaging services for commercial medicines, medical devices, animal health medicines and consumer healthcare products.

Prior to joining PCI, Ms. Ertl worked for GlaxoSmithKline, Johnson & Johnson, and Wyeth (Pfizer). Her career features a background in quality and compliance. She brings experience including investigation writing, regulatory inspections, risk and data integrity assessment, training development, procedure development, change management systems, remediating CAPAs, and working with batch documentation.

“We are delighted to have Melissa join PCI,” said Jeannie Metzinger, vice president of quality, PCI. “Melissa brings extensive knowledge and experience across a number of leading pharmaceutical companies which will be an asset to our organization. Her commitment to quality and continuous improvement aligns with the company’s vision to provide the industry’s leading customer experience for our clients and supporting lifesaving medicines to patients around the world.”

The Philadelphia facility recently expanded its serialization and anti-counterfeiting capacity in support of domestic and international requirements, as well as investment in additional commercial packaging lines for capacity expansion. Other notable capital investments include the on-site capacity expansion of the sites 2-8°C cold chain storage, complementing expansive cold Ccain capabilities across our commercial and clinical supply network.